The systemic immune response measured in spleen lymphocytes consisted of R-337-mediated increase in CD8+/CD45+ lymphocytes, decrease in CD11+ cells, and increase in PD-L1 in CD45+ lymphocytes; the modifications were similar to those seen in the tumor specimens (Figure 4R–T). Here, PTPRC is linked to neoplasm.